1971至1998年纳入EORTC CLG研究的儿童急性淋巴细胞白血病长期生存者的生育状况:58项远期不良反应研究结果
该研究纳入1971至1998年法国和比利时EORTC研究中确诊的儿童急性淋巴细胞白血病生存者,507例参与(女277例,男230例),按年龄、省、城市化水平和性别1:1匹配503例一般人群对照。结果显示除男性生存者伴侣流产比例较高外,男女生存者生育结局与对照相当。
要点
- 儿童急性淋巴细胞白血病长期生存者生育结局与一般人群对照相当。
- 男性生存者伴侣流产比例为28.1%,高于对照的5.9%(P=0.021)。
- 女性生存者诊断年龄10-17岁与妊娠问题风险升高相关(校正OR 5.61,P=0.046)。
核心结论
- 儿童急性淋巴细胞白血病生存者与对照的生育结局相似,但男性生存者伴侣流产比例较高。
研究设计与样本
- 研究纳入1971至1998年法国和比利时EORTC研究中确诊的儿童急性淋巴细胞白血病患者,诊断时<18岁、随访时存活且≥18岁者符合条件。
- 1418例符合条件生存者中507例(35.8%)参与,其中女性277例、男性230例;503例生存者按年龄、省、城市化水平和性别1:1匹配到一般人群对照。
- 采用问卷收集月经周期、生育意愿、生育情况、医疗助孕使用及不良妊娠结局等信息,男女分别分析。
- 采用logistic回归分析诊断年龄与生育结局的关联,校正随访年龄、研究和国家。
主要发现
- 诊断后中位时间为20.1年,随访时中位年龄为25岁。
- 144例生存者(女97例、男47例)有生育意愿,其中18%接受过颅脊放疗、4%接受过造血干细胞移植。
- 尝试生育者中,女性生存者75%成功、男性生存者69%成功,对照分别为72%和61%,差异无统计学显著(女性P=0.73,男性P=0.50)。
- 男性生存者伴侣流产比例为28.1%,高于对照的5.9%(P=0.021)。
- 女性生存者诊断年龄10-17岁与妊娠问题风险升高相关(校正OR 5.61,P=0.046)。
局限性
- 男性生存者伴侣流产发生率的解读受限于缺乏男性伴侣数据,且男性生存者可能比男性对照更倾向于回忆和披露生育问题。
- 作者指出进一步研究应确认男性生存者伴侣流产比例较高这一现象。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What are the fertility outcomes of male and female childhood acute lymphoblastic leukaemia (ALL) long-term survivors? SUMMARY ANSWER: We observed similar fertility outcomes in both male and female childhood ALL survivors compared with the general population, with the exception of a higher proportion of miscarriages among partners of male survivors. WHAT IS KNOWN ALREADY: Survival after childhood ALL is currently >90% and fertility impairments are among the main concerns of the long-term survivors. Few studies have focused on the fertility issues within this selected population and the existing data are difficult to interpret due to the different treatment regimens received by the patients, the small sample sizes and the unavailability of control data in many studies. STUDY DESIGN, SIZE, DURATION: Childhood ALL patients enrolled in European Organisation for Research and Treatment of Cancer (EORTC) studies between 1971 and 1998 in France and Belgium, <18 years old at diagnosis and alive and ≥18 years at follow-up were eligible. Among 1418 eligible survivors, 507 (35.8%) participated (277 females, 230 males). Controls from the general population matched one to one by age, province, level of urbanization and sex could be identified for 503 survivors. PARTICIPANTS/MATERIALS, SETTING, METHODS: Survivors and controls were invited to fill out a questionnaire including information about their menstrual cycles (for females), intention to have children, having children, use of medical help to become pregnant and occurrence of negative pregnancy outcomes (birth defect, miscarriage, medical abortion or stillbirth). The results were analysed separately for females and males. The association between age at diagnosis and fertility outcomes, adjusted by age at follow-up, study and country were investigated using logistic regression. MAIN RESULTS AND THE ROLE OF CHANCE: The median time since diagnosis was 20.1 years and the median age at follow-up was 25 years. There were 144 survivors (97 females, 47 males) who wanted to have children. Among these, craniospinal radiotheraphy (CRT) and haematopoietic stem cell transplantation (HSCT) were administered to 18% and 4%, respectively. Of these who tried to have children, 75% of females and 69% of males succeeded, compared with 72% and 61% of the controls, respectively. These differences were not statistically significant (P = 0.73 for females and P = 0.50 for males). Overall, fertility outcomes were comparable between survivors and controls, except that a higher proportion of miscarriages occurred in partners of male survivors (28.1% versus 5.9%, P = 0.021). Among female survivors, an older age at diagnosis (10-17 years) was associated with a greater risk of pregnancy problems (adjusted OR 5.61, P = 0.046). LIMITATIONS, REASONS FOR CAUTION: The interpretation of the incidence of miscarriage among the partners of male survivors is limited by the lack of data regarding the males' partners and by a possibly higher tendency to recall and disclose fertility issues among male survivors compared with male controls. WIDER IMPLICATIONS OF THE FINDINGS: Fertility outcomes were similar in childhood ALL survivors and controls, and the low proportion of patients treated with CRT or HSCT might explain this. Further studies should confirm the higher proportion of miscarriages in partners of male survivors. STUDY FUNDING/COMPETING INTEREST(S): This publication was supported by donations from the Fonds Cancer (FOCA) from Belgium and the KU Leuven from Belgium. G.R. has been awarded a fellowship by the EORTC Cancer Research Fund (ECRF). C.P. has been awarded a fellowship by Fonds Cancer (FOCA) from Belgium and the Kinderkankerfonds from Belgium (a non-profit childhood cancer foundation under Belgian law). No competing interests were declared. TRIAL REGISTRATION NUMBER: NCT01298388 (clinicaltrials.gov).
引用
- Rossi G, Kicinski M, Suciu S, et al. Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study. Hum Reprod. 2021. PMID: 34788455. doi:10.1093/humrep/deab236
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。